Catherine Brenner
Overview
Explore the profile of Catherine Brenner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
7162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Patria L, Habel N, Olaso R, Fernandes R, Brenner C, Stefanovska B, et al.
J Exp Clin Cancer Res
. 2025 Mar;
44(1):83.
PMID: 40038783
Background: Osteosarcoma is the most prevalent cancer-related bone disease diagnosed in the pediatric age group. The rapid development of metastatic lesions and resistance to chemotherapy remain major mechanisms responsible for...
2.
Lacroix A, Farhat R, Robert A, Brenner C, Wiels J, Germini D
Front Pharmacol
. 2024 Aug;
15:1444973.
PMID: 39170706
Ovarian adenocarcinoma is the gynecological malignancy with the worst prognosis and the highest mortality rate. In the first stages of treatment, chemotherapy results effective, but its prolonged use and high...
3.
Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D, et al.
Cell Death Differ
. 2023 Apr;
30(5):1097-1154.
PMID: 37100955
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have...
4.
Tran B, Gelin A, Durand S, Texier M, Daste A, Toullec C, et al.
Oncoimmunology
. 2022 Dec;
12(1):2150472.
PMID: 36545254
Extra-cellular galectins 1, 3 and 9 (gal-1, -3 and -9) are known to act as soluble immunosuppressive agents in various malignancies. Previous publications have suggested that their expression is dependent...
5.
Nedara K, Reinhardt C, Lebraud E, Arena G, Gracia C, Buard V, et al.
Front Oncol
. 2022 Nov;
12:958155.
PMID: 36387192
Human TRIAP1 (TP53-regulated inhibitor of apoptosis 1; also known as p53CSV for p53-inducible cell survival factor) is the homolog of yeast Mdm35, a well-known chaperone that interacts with the Ups/PRELI...
6.
Lai H, Naumova N, Marchais A, Gaspar N, Geoerger B, Brenner C
Front Cell Dev Biol
. 2022 Sep;
10:948097.
PMID: 36072341
Osteosarcoma (OS) is a pediatric malignant bone tumor that predominantly affects adolescent and young adults. It has high risk for relapse and over the last four decades no improvement of...
7.
Corporeau C, Petton S, Vilaca R, Delisle L, Quere C, Le Roy V, et al.
Mar Environ Res
. 2022 Aug;
180:105709.
PMID: 35988349
The Pacific oyster Crassostrea gigas is established in the marine intertidal zone, experiencing rapid and highly dynamic environmental changes throughout the tidal cycle. Depending on the bathymetry, oysters face oxygen...
8.
Ichim G, Gibert B, Adriouch S, Brenner C, Davoust N, Desagher S, et al.
Biomolecules
. 2022 Jul;
12(7).
PMID: 35883457
Since the Nobel Prize award more than twenty years ago for discovering the core apoptotic pathway in , apoptosis and various other forms of regulated cell death have been thoroughly...
9.
Lai H, Canoy R, Campanella M, Vassetzky Y, Brenner C
Cells
. 2022 Mar;
11(5).
PMID: 35269437
Hepatocellular carcinoma (HCC) is a type of liver cancer with a poor prognosis for survival given the complications it bears on the patient. Though damages to the liver are acknowledged...
10.
Liu D, Peyre F, Loissell-Baltazar Y, Courilleau D, Lacas-Gervais S, Nicolas V, et al.
Cells
. 2022 Feb;
11(3).
PMID: 35159285
Improvement of anticancer treatments is associated with increased survival of cancer patients at risk of cardiac disease. Therefore, there is an urgent need for new therapeutic molecules capable of preventing...